| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
47,298,000 | 47,056,000 | 45,360,000 | 42,912,000 | 39,796,000 |
| Cost of Revenue
|
-37,555,000 | -37,301,000 | -35,449,000 | -33,566,000 | -31,232,000 |
|
Gross Profit
|
9,743,000 | 9,756,000 | 9,912,000 | 9,347,000 | 8,565,000 |
| Selling, General and Administrative Expenses
|
-4,382,000 | -4,382,000 | -4,290,000 | -4,236,000 | -4,011,000 |
|
Research and Development Expenses
|
-330,000 | -330,000 | -290,000 | -296,000 | -265,000 |
| Depreciation, Amortization and Depletion
|
-141,000 | -141,000 | -108,000 | -69,000 | -48,000 |
| Other Income/Expense, Operating
|
-1,120,000 | -1,120,000 | -1,105,000 | -1,030,000 | -860,000 |
|
Operating Income/Expenses
|
-5,947,000 | -5,973,000 | -5,793,000 | -5,631,000 | -5,184,000 |
|
Total Operating Profit/Loss
|
3,796,000 | 3,783,000 | 4,119,000 | 3,716,000 | 3,381,000 |
| Total Net Finance Income/Expense
|
69,000 | 53,000 | 0 | 0 | -2,000 |
| Net Investment Income
|
11,000 | 10,000 | 25,000 | 0 | -4,000 |
| Irregular Income/Expenses
|
-2,000 | -2,000 | 0 | -23,000 | -28,000 |
|
Other Income/Expense, Non-Operating
|
1,000 | 1,000 | 1,000 | -3,000 | -2,000 |
|
Non-Operating Income/Expenses, Total
|
79,000 | 62,000 | 26,000 | -26,000 | -36,000 |
|
Pretax Income
|
3,871,000 | 3,840,000 | 4,139,000 | 3,686,000 | 3,334,000 |
| Provision for Income Tax
|
-1,259,000 | -1,195,000 | -1,197,000 | -1,092,000 | -962,000 |
|
Net Income from Continuing Operations
|
2,612,000 | 2,645,000 | 2,942,000 | 2,594,000 | 2,372,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
2,611,000 | 2,645,000 | 2,941,000 | 2,593,000 | 2,372,000 |
|
Net Income after Non-Controlling/Minority Interests
|
2,611,000 | 2,645,000 | 2,941,000 | 2,593,000 | 2,372,000 |
|
Net Income Available to Common Stockholders
|
2,611,000 | 2,645,000 | 2,941,000 | 2,593,000 | 2,372,000 |
|
Diluted Net Income Available to Common Stockholders
|
2,611,000 | 2,645,000 | 2,941,000 | 2,593,000 | 2,372,000 |
| Basic EPS
|
135.46 | 137.21 | 152.56 | 134.52 | 123.05 |
| Diluted EPS
|
135.44 | 137.20 | 152.56 | 134.52 | 123.05 |
|
Basic Weighted Average Shares Outstanding
|
19,277.77 | 19,277.82 | 19,278.14 | 19,275.94 | 19,276.09 |
|
Diluted Weighted Average Shares Outstanding
|
19,277.79 | 19,277.93 | 19,278.21 | 19,275.94 | 19,276.39 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
3,802,000 | 3,787,000 | 4,139,000 | 3,686,000 | 3,336,000 |
|
EBITDA
|
4,567,000 | 4,567,000 | 4,819,000 | 4,378,000 | 3,952,000 |
|
Normalized EBITDA
|
4,571,000 | 4,571,000 | 4,819,000 | 4,401,000 | 3,980,000 |
|
Normalized Income
|
2,613,349.52 | 3,843,000 | 4,139,000 | 3,709,000 | 3,366,000 |
3/31/2023 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade